Severe Acute Respiratory Infections (SARI) in Belgium (2011-2020)

NCT05620953 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12145

Last updated 2023-09-08

No results posted yet for this study

Summary

The Belgian Severe Acute Respiratory Infections network (BELSARI-net) was implemented during the influenza season 2011-2012 following the recommendations of the World Health Organization (WHO) to monitor severity of influenza viruses in hospitals. The network is composed of 6 hospitals throughout the country, two in each administrative region (Flanders, Wallonia and Brussels-Capital), and operates during the influenza epidemic period (from the last week of December or first/second week of January to the third/last week of April, depending on when influenza virus circulation is detected by the general population, based on the Influenza-like illness (ILI) network of general practitioners).

Enrollment is performed for all cases matching the SARI case definition (based on WHO's case definition) and accepting to take part. A respiratory specimen is sampled systematically from each participant, and detailed clinico-epidemiological data, such as information on age, sex, symptoms and potential risk factors such as pregnancy or comorbidities (chronic respiratory diseases, asthma, chronic cardiovascular diseases, renal insufficiency, obesity, diabetes, hepatic or renal insufficiency, immunodeficiency, neuromuscular disease, pregnancy) is also collected. Participants are followed up during hospitalization for the occurrence of complications (detection of pneumonia based on chest radiography, development of acute respiratory distress syndrome (ARDS), requirement for respiratory assistance and/or for extracorporeal membrane oxygenation (ECMO), admission in intensive care unit (ICU)), or death (all-cause death).

The current project includes all the samples received by the Belgian National Influenza Centre (NIC) during the influenza seasons 2011-2012 till 2019-2020.

Conditions

  • Influenza Viral Infections
  • Respiratory Viral Infection
  • Severe Acute Respiratory Infection

Interventions

DIAGNOSTIC_TEST

respiratory specimen

nasopharyngeal swab or nasal aspiration or broncho-alveolar lavage

Sponsors & Collaborators

  • Belgian Federal Public Service, Food Chain Safety and Environment

    collaborator OTHER_GOV
  • Centre Hospitalier Universitaire Saint Pierre

    collaborator OTHER
  • AZ Sint-Jan AV

    collaborator OTHER
  • Universitair Ziekenhuis Brussel

    collaborator OTHER
  • Grand Hôpital de Charleroi

    collaborator OTHER
  • Jessa Hospital

    collaborator OTHER
  • Centre Hospitalier Universitaire UCLouvain Namur

    collaborator OTHER
  • Sciensano

    lead OTHER_GOV

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-20
Primary Completion
2020-04-02
Completion
2020-04-02

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05620953 on ClinicalTrials.gov